Posts belonging to Category Industry



EU warns Trump’s car tariffs threaten $300 billion of US exports

20% of US exports at risk

Nearly $300 billion of US exports could be hit by retaliatory tariffs if the Trump administration decides to penalize automobile imports from around the world, the European Union says.

The Commission said global retaliation against US tariffs on auto imports would have a much bigger impact on the American economy than the backlash provoked by the Trump administration’s steel and aluminum tariffs this year. It estimated that $294 billion, or around 19% of total US exports last year, could be affected.

President Donald Trump has threatened to place a 20% tariff on all European cars coming to the United States if the European Union doesn’t remove its own trade barriers. In May, the US government launched an investigationinto imports of automobiles, including SUVs, light trucks and auto parts.

The type of investigation, known as Section 232, is meant to determine whether the imports are hurting US national security. It’s the same approach the Trump administration used before it slapped tariffs on steel and aluminum imports earlier this year.

https://www.cnn.com/

Amazon Makes $1 Billion Splash in Health Care, Buying PillPack

Formidable challenge to pharmacy chains 

Amazon.com Inc. is buying its way into the heart of the U.S. health-care system, instantly shaking up a prescription-drug industry already in the midst of a broader transformation. Insurance companies and drug-benefit managers have struck a series of deals in recent months designed in part to thwart a potential big splash in the health world from Amazon. But the online retail giant’s decision to buy online pharmacy PillPack rapidly accelerates the threat posed to entrenched retailers, suppliers and middlemen.

Most immediately, the move represents a formidable challenge to pharmacy chains including Walgreens Boots Alliance Inc. and CVS Health Corp., the two largest drugstore chains in the U.S. Walgreens shares sank 8.5 percent at 10:49 a.m. in New York, while CVS shares shed 8.9 percent.

https://www.bloomberg.com/

Trade war: Harley-Davidson shifts some production out of the U.S.

Trump last year thanked the company for “building things in America.”

On Monday, Harley-Davidson Inc. said it would shift some production out of the U.S. in order to mitigate the impact of European Union tariffs targeting its motorcycles. Those penalties — which Harley-Davidson estimates may cost it as much as $100 million annually — were in response to U.S. levies on steel and aluminum imported from the EU. Meanwhile, the Treasury Department is reportedly planning to aim a bazooka at a Chinese takeover problem that doesn’t really exist anymore by declaring a national economic emergency. What’s more troubling is a reported plan to crack down on exports of key U.S. technologies.

https://www.bloomberg.com/

Brexit: Airbus ‘set to quit’ UK

Tens of thousands of jobs at risk

Aerospace giant Airbus is preparing to quit Britain due to fears of a hard Brexit, potentially putting tens of thousands of jobs at risk, it was reported last night.

The European aerospace company, said to generate £1.7billion a year in tax, is set to abandon plans to build aircraft wings at its British plants, according to The Times.

Production will be moved to China, the US or elsewhere in Europe, rather than taking place here as was previously hoped. Airbus, which has factories in Bristol, Portsmouth, Stevenage and Broughton in north Wales, employs 14,000 people in the UK while a further 110,000 jobs are supported by its supply chain.

https://www.metronews.com/

The shipping industry is back

Indicator of the health of the global economy

90 percent of today’s global trade is carried by ship. The importance of shipping is why it’s one of the most useful indicators of the health of the global economy… And, more recently, the state of China’s economy – the largest consumer of a range of commodities, including iron ore, coal, copper, and zinc, and the largest importer of oil.

The Baltic Dry Index (BDI) tracks the price of shipping raw materials such as metals, grains and fossil fuels by sea. It takes into account the day-to-day changes in shipping rates for the three major carrier sizes: Capesize, Panamax and Supramax.

Shipping companies committed a classic boom/bust cycle mistake back in 2011. At the height of the commodity boom, they ordered a huge number of cargo ships. Global shipping capacity continued to expand by approximately a net 2.5 percent rate each and every year. Meanwhile, according to the World Bank, global trade of goods and services has declined by 7 percent from 2011 to 2016, as commodity prices collapsed.

https://www.businessinsider.com/

Driverless cars similar to antibiotics says Carlos Ghosn

We’re Five Years From Safe, Driverless Cars For All

Carlos Ghosn, CEO of the Renault-Nissan-Mitsubishi Alliance,  has detailed the impact of the driverless car on human daily lives (Interview at BFMTV). There are between 1,3 million and 1,4 million death on roads every year in the world. The driverless car will eliminate 90% of the fatal accidents.

https://www.forbes.com/

Trade War: Canada Retaliates

Tariffs on $12.8 Billion of U.S. Goods

Prime Minister Justin Trudeau retaliated swiftly against President Donald Trump’s metals tariffs by imposing his own levies on as much as C$16.6 billion ($12.8 billion) of U.S. imports in what Canada calls its strongest trade action since the Second World War.

Trudeau invoked decades of battles fought alongside the U.S. and defending North American airspace as proof the U.S. tariffs based on a national security investigation are “unacceptable” and “punitive.” The Canadian tariffs of 25 percent on steel and 10 percent on aluminum will aim to match U.S. penalties on a dollar-for-dollar basis, based on export values, according to Foreign Affairs Minister Chrystia Freeland.

https://www.bloomberg.com/

Donald Trump’s trade war with Europe looks inevitable

EU says it is ready to wage trade war with US

The Trump administration is reportedly planning to impose import tariffs on European steel and aluminum after finding no satisfaction in its effort to win trading concessions on the issue.

An announcement dropping the EU from an exemption to global tariffs of 25% on imported steel, and 10% on aluminum, could come on Thursday, according to the Wall Street Journal.

The move is likely to bring retaliatory action from European Union trade regulators who have warned they will target American products as motorcycles, jeans and bourbon if additional US tariffs are imposed.

https://www.theguardian.com/

The US offshore wind industry is about to take off

8 States have approved plans to build wind farms

There are only five wind turbines operating in U.S. waters today. But that will likely soon change, partly because of states with ambitious offshore wind targets.

Massachusetts, for example, is about to pick one of the three bids it got from companies vying to build one of the nation’s first commercial-scale offshore wind farms. Equipped with the capacity to generate enough electricity to power as many as 150,000 homes, the turbines located about 20 miles southwest of Martha’s Vineyard would be among several big offshore wind projects that could transform the grid.

https://www.businessinsider.com/

Takeda buys Shire for $62 billion

Stock decline nearly 20 percent due to doubts about the deal

After five proposals and more than month of back-and-forth, it looks like this thing is happening. Takeda Pharmaceutical Co Ltd. agreed Tuesday to purchase rare-disease drugmaker Shire Plc for $62 billion. But this blockbuster deal comes with blockbuster risk. Takeda will be paying a steep premium and taking on big debt to acquire a company with uncertain prospects.
Takeda’s desire for geographic and drug diversification led it to overlook a lot of warts. Shire’s hemophilia business provides more than a quarter of its revenue. It faces near-term peril from Roche Holding AG’s recently launched Hemlibra, and long-term threats from potential one-time treatments being developed by companies such as BioMarin Pharmaceutial Inc. that could reduce demand for Shire’s older drugs.

Shire has an attractive pipeline of high-margin rare-disease drug candidates, but its research projects will have to over-deliver in order to compensate for competitive threats to current core business. The substantial research and development cuts that Takeda plans if the deal goes through won’t help.

 https://www.bloomberg.com/